Strategic report Governance Financial statements Other information NOMINATION COMMITTEE REPORT CONTINUED Director independence, time commitment and re-election In concluding that each of the Non-Executive Directors has Nomination Committee priorities for 2021/22 The Committee conducted its annual review of the independence sufficient time available to allocate to the Company as set outLooking ahead to the next financial year, it is anticipated that of the Non-Executive Directors, and time commitments of the in their letters of appointment, the Committee considered the the Committee will focus in particular on: Directors generally, at its June meeting . In reviewing the detailed requirements of the Code and the Capital Requirements The recruitment of a new Chief Financial Officer; independence of the Non-Executive Directors, the Committee Directive (CRD IV), attendance records for each Director and • considered in detail whether any circumstances have arisen, responsiveness to Company business, as well as the confirmations •The Group’s succession planning throughout the organisation including those set out in Provision 10 of the Code, which are likelygiven to the Chair by each of the Non-Executive Directors thatwith a key focus on enhancing a diverse talent pipeline; to impair, or could appear to impair the independence of each they continue to have sufficient time to discharge their Reinstating the ‘evergreen’ approach to succession planning to Non-Executive Director. This included consideration of length ofresponsibilities effectively.In addition to each Non-Executive • tenure, existing and proposed external directorships and otherDirector’s current responsibilities, the Chair has reviewed and proactively anticipate successional demands and to develop a similar appointments, and any other conflicts recorded by the discussed plans and timing for adding new or deleting current pipeline of talent with the skills and capabilities that align to the Company in respect of each Non-Executive Director. responsibilities to ensure each individual’s time commitment future strategic needs of the business; The Committee concluded that it considered each of the remains consistent. •Overseeing the 2021 external Board evaluation; and Non-Executive Directors other than the Nominated Director to As part of its review of the size, structure and composition of the •Creating an orderly future rotation plan for the Board members. be independent under the provisions of the Code. As an appointeeBoard, and taking into account its assessment of independence of a shareholder, the Nominated Director is not considered to beand time commitments, the Committee is satisfied that the Board independent but he is considered to be a valuable addition to thecontinues to be effective. Based on its assessment of each Deanna Oppenheimer Board because he provides an avenue to harness Peter Hargreaves’Director’s performance and ability to continue to contribute to theChair of the Nomination Committee experience as well as his own wealth of experience in the fundBoard in light of the knowledge, skill and experience they possess, management industry. The Nominated Director does not sit on the Committee has recommended to the Board that each of the 8 August 2021 any of the Committees and giventhat the majority of the Non- Directors is putorward for election or re-election at the 2021 AGMf Executive Directors are independent, the Committee considers as appropriate. this adequately compensates for any potential imbalance that may arise from the presence of the Nominated Director. 120 Hargreaves Lansdown Report and Financial Statements 2021